ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Oct 13, 2014 20:00 JST
China Mobile Games & Entertainment Group Fundamentals Still Solid; Buy into Dips
HONG KONG, Oct 13, 2014 - (ACN Newswire) - CICC maintain "BUY" rate and raise the target price by 32% from US$19 to US$25 on China Mobile Games and Entertainment Group Limited ("CMGE" or the "Company")
(Nasdaq: CMGE), a leading mobile game company in China.
3Q14 rev. close to high end of guidance, pipeline strong
CICC expect 3Q14 revenue to grow 245% YoY / 23% QoQ to Rmb338mn, and non-GAAP NI to grow 213% YoY / 24% QoQ to Rmb78mn. Strong results were helped by Super Hero, Tiantian Hero, and increasing revenue from self-developed card & board games.
Trends to watch
Winner in the consolidation of mobile game publishing business.
CICC see that CMGE has benefited from mobile game publisher consolidation and has been taking more and more market share. CICC favor CMGE's independent role as a mobile game publisher and believe industry growth coupled with market share gains can help CMGE deliver strong performance.
Strong 4Q14 pipeline to contribute to rapid growth in 2015.
CMGE launched CA (FPS) and The New Legend (APRG) in late September, both delivered monthly gross billings of over Rmb20mn. CMGE has a robust pipeline in 4Q14, CICC believe Feng Zhong Qi Yuan (the same IP as the popular TV drama), Age of Discovery, Naruto and One Piece are among the most awaited games.
Management concerns to disappear with smooth operations.
The market is over-concerned with CMGE's management issues. As the company performs well, market concerns will gradually be erased, and corporate restructure will prove to be more efficient as margins improve.
Valuation and recommendation
CMGE's share price was at one point 100% higher than the last call in August; though it experienced a pullback due to systematic risk, the current share price is still 18% higher than the initial coverage on August 5, 2014. CICC lower 2014 EPS by 11.5% to Rmb8.6 and increase 2015 EPS by 10.3% to 15.4. CICC believe the recent correction provides a good opportunity to buy and raise the target price by 32% from US$19 to US$25, as removed the management risk discount of 20% and raised 2015 earnings forecast by 8.3%. Maintain BUY rating. TP represents 2014/15 PER of 18x/10x.
Sectors: Media & Marketing, Daily Finance, IT Individual, Daily News
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Honda Running Team Member, Nagiya Mori, Selected to Represent Japan in World Athletics Championships Tokyo 25 (WCH Tokyo 25) Men's 5000m Event
Sep 03, 2025 12:30 JST
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status
Sep 03, 2025 11:32 JST
Anime Tokyo Station: TV Anime "SPY x FAMILY" Special Exhibition, Period: August 16 - November 9, 2025
Sep 03, 2025 11:00 JST
Fujitsu, 1Finity and Arrcus sign strategic partnership agreement to deliver innovative network solutions for AI infrastructure
Sep 03, 2025 10:58 JST
Mitsubishi Corporation Invests in Commonwealth Fusion Systems, a US Fusion Energy Start-up from MIT
Sep 02, 2025 12:50 JST
Hitachi has been certified as a Gold Partner of Scaled Agile, Inc., the provider of the large-scale agile framework "SAFe(R)"
Sep 02, 2025 11:50 JST
ABVC BioPharma Receives $450,000 in Licensing Payments from OncoX BioPharma in Q3 2025
Sep 01, 2025 22:28 JST
DENSO Signs Agreement to Transfer Part of Its Ceramic Product Business
Sep 01, 2025 20:52 JST
Honda to Provide Official Vehicles for World Athletics Championships Tokyo 25 as Official Global Partner
Sep 01, 2025 13:50 JST
FDA Approves LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Sep 01, 2025 13:44 JST
TANAKA Memorial Foundation to Offer Precious Metals Research Grants of Up to 10 Million Yen (from a Grant Pool of 20 Million Yen) - Applications for Research Projects Open on September 1
Sep 01, 2025 11:00 JST
ABVC BioPharma Receives $450,000 in Licensing Payments from OncoX BioPharma in Q3 2025
Aug 29, 2025 20:39 JST
Honda Announces New Plan for Relocation of Global Head Office to Yaesu Area in Tokyo and Reconstruction of Honda Aoyama Building
Aug 29, 2025 18:54 JST
Ministry Of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anticancer Agent Tazemetostat for Unresectable INI1-Negative Epithelioid Sarcoma
Aug 29, 2025 18:17 JST
Hitachi Energy acquires remaining stake of eks Energy, reinforcing leadership in power conversion systems for energy storage
Aug 29, 2025 15:17 JST
Hong Kong Watch & Clock Fair, Salon de TIME return in September
Aug 28, 2025 21:27 JST
SenseTime Announces 2025 Interim Results
Aug 28, 2025 21:20 JST
Ausnutria 2025 Interim Results Announcement: Revenue and Profit Maintain Resilient Dual Growth
Aug 28, 2025 19:09 JST
Baguio Green Group (1397.HK) Announces 2025 Interim Results
Aug 28, 2025 19:03 JST
Production, Sales and Export Results for July, 2025
Aug 28, 2025 17:36 JST
More Latest Release >>